跳至主要内容
临床试验/EUCTR2014-001406-17-NL
EUCTR2014-001406-17-NL进行中(未招募)不适用

Ventilator Associated Pneumonia: addition of Tobramycin Inhalation antibiotic treatment to standard IV antibiotic treatment

Erasmus MC0 个研究点目标入组 84 人开始时间: 2014年8月5日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Erasmus MC
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • The clinical suspicion of pneumonia is based on the ATS criteria:
  • -new or progressive radiologic pulmonary infiltrate
  • Together with at least two of the following three criteria:
  • -temperature >38°C
  • -leukocytosis >12,000/mm3 or leucopenia <4,000/mm3
  • -purulent respiratory secretions
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 54

排除标准

  • patients with allergy to tobramycin; pregnancy; expected to die within 72
  • hours after enrollment

研究者

发起方
Erasmus MC

相似试验